5 Tough Questions for Bristol-Myers Squibb's CEO
Giovanni Caforio has been at the helm of Bristol Myers Squibb NYSE BMY for less than two years But he s gotten used to answering tough questions On Thursday morning the big drugmaker s CEO sat down for around 40 minutes responding to nonstop questions at the Goldman
Read more »